Rephonic
Artwork for Research To Practice

Research To Practice | Oncology Videos

Dr Neil Love
Immunotherapy
Prostate Cancer
Chronic Lymphocytic Leukemia
Ovarian Cancer
PARP Inhibitors
Endometrial Cancer
Colorectal Cancer
Multiple Myeloma
Pembrolizumab
Small Cell Lung Cancer
HER2
Follicular Lymphoma
Gastroesophageal Cancer
Breast Cancer
Diffuse Large B-Cell Lymphoma
Bispecific Antibodies
Antibody-Drug Conjugates
Cdk4-6 Inhibitors
Circulating Tumor DNA
Non-Small Cell Lung Cancer

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.

PublishesDailyEpisodes1524Founded13 years ago
Number of ListenersCategories
ScienceHealth & FitnessMedicine

Listen to this Podcast

Artwork for Research To Practice

Latest Episodes

Featuring perspectives from Dr Joyce F Liu, Dr David M O'Malley and Dr Brian M Slomovitz, moderated by Dr O'Malley, including the following topics:

• Case: A woman in her mid 60s with Stage II uterine carcinosarcoma treated with surgery followed b... more

Featuring an interview with Dr L Elizabeth Budde, including the following topics:

• Considerations for selecting between bispecific antibodies (BsAbs); monotherapy versus combination therapy (0:00)

• Management of BsAb-induced cytokine release sy... more

Featuring a slide presentation and related discussion from Dr L Elizabeth Budde, including the following topics:

• Overview of approved and investigational CD20 x CD3 bispecific antibodies (BsAbs) in non-Hodgkin lymphoma; key findings from Phase ... more

Featuring perspectives from Dr Stephen V Liu and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics:

• Introduction (0:00)

• EGFR Mutations (2:23)

• HER2 Alterations (22:40)

• Available and Investigational Immunoth... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Elizabeth Budde
Clinical investigator; expert in hematologic malignancies
City of Hope National Medical Center, Duarte, California
Episode: Diffuse Large B-Cell Lymphoma — An Interview with Dr L Elizabeth Budde on Employing CD20 x CD3 Bispecific Antibodies
Dr. Stephen Liu
Oncologist from Georgetown University
Georgetown University
Episode: Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
Dr. Neeraj Agarwal
Professor of Medicine and Director of Geo-Oncology Program at Huntsman Cancer Institute
Huntsman Cancer Institute, University of Utah
Episode: Prostate Cancer with PTEN Deficiency — An Interview with Dr Neeraj Agarwal (Companion Faculty Lecture)
Ann LaCasce
Oncologist, Dana-Farber/Brigham and Women's Cancer Center
Dana-Farber Cancer Institute
Episode: Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
Ursula Matulonis
Medical oncologist
Data Farber Cancer Institute
Episode: HER2-Positive Gynecologic Cancers — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
Shannon Westin
Medical oncologist discussed as a guest; speaker introduced as a specialist in Gynecologic Oncology
University of Texas MD Anderson Cancer Center
Episode: Ovarian and Endometrial Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
Alexander Drilon
Dr. Alexander Drilon, Memorial Sloan-Kettering Cancer Center, New York
Memorial Sloan Kettering Cancer Center
Episode: For Oncology Nurses: Non-Small Cell Lung Cancer with a ROS1 Fusion — An Interview with Dr Alexander E Drilon
Brad Kahl
Medical oncologist; Washington University in St. Louis; expert in NHL/CLL
Washington University School of Medicine
Episode: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Reviewing Recent Datasets from the 2026 ASCO Annual Meeting and EHA2026 Congress
Tanya Siddiqi
Medical oncologist; City of Hope; expert in NHL/CLL
City of Hope
Episode: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Reviewing Recent Datasets from the 2026 ASCO Annual Meeting and EHA2026 Congress

Hosts

Neil Love
Host from Research To Practice; frequently guides discussions and presents consensus updates; associated with multiple program strands including Year in Review and CME-linked content.
Seth Wander
Moderator from Boston introducing and guiding the session.
Misty Shields
Host of Second Opinion CME meeting; coordinates session flow.
Yelena Janjigian
Moderator of the discussion; prominent oncology expert.
John Heymach
Oncologist presenting expert insights; thoracic oncology focus.

Reviews

4.6 out of 5 stars from 156 ratings
  • Still the best and still addicted!

    I am a retired pharmacist and my husband still listens with me. Dr. Love is the best at getting to what is important for day to day treatment. Soooo good I can’t give it up. Thank you all for continuing be an inspiration to this old woman. In my next life……….❤️

    Apple Podcasts
    5
    Redbat7
    United Statesa month ago
  • Valued resource

    Relentless in its focus on the general medical oncolgist. An important resource.

    Apple Podcasts
    5
    a h/o
    United States5 years ago
  • Excellent

    Since my fellowship training Neil Love has made these presentations the best of the best in staying UpToDate with current and future practice

    Apple Podcasts
    5
    obete man
    United States5 years ago
  • RTP is is consistently great

    Research to Practice continues to put out well produced clinically relevant content from expert faculty that is applicable to daily oncology practice. It is an invaluable resource for me.

    Apple Podcasts
    5
    OKMedStudent
    United States6 years ago
  • Gold standard

    I’m not an oncologist but I love listening to all of these podcasts. I have to imagine that Neil Love is an absolute giant in this field. So interesting and informative.

    Apple Podcasts
    5
    Bob a la sob mob
    United States7 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

- Appreciated even by non-oncologists for its informative discussions.
- Valuable resource for staying current with general medical oncologists.
- Consistently high-quality, clinically relevant content from expert faculty.
- A well-produced source of practical oncology knowledge for daily practice.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#144
Hong Kong/Science
Apple Podcasts
#161
China/Science
Apple Podcasts
#194
Brazil/Science
Apple Podcasts
#205
Saudi Arabia/Science
Apple Podcasts
#216
Ireland/Science

Talking Points

Recent interactions between the hosts and their guests.

Glucocorticoid Receptor Antagonists for Ovarian Cancer — An Interview with Professor Nicoletta Colombo
Q: Do we know actually whether or not exogenous corticosteroids actually affect relacorrelant mechanism? It's more theoretical. Do we have any clinical data?
Colombo notes that while there are theoretical concerns about steroids interfering with relacorlan, clinical data are limited and the practical approach has been to use the minimum effective steroid dose, as robust data on this interaction are lacking.
Prostate Cancer with PTEN Deficiency — An Interview with Dr Neeraj Agarwal
Q: How should clinicians approach testing for PTEN loss in practice, especially when tissue is limited?
Prioritize NGS for broad mutational profiling, perform IHC for PTEN loss when possible, and if tissue is insufficient, advocate for a new metastatic biopsy to enable targeted therapy decisions; germline testing should also be done.
Prostate Cancer with PTEN Deficiency — An Interview with Dr Neeraj Agarwal
Q: What is the biological rationale for targeting the PI3K-AKT-mTOR pathway in PTEN-deficient prostate cancer?
PTEN loss removes a critical brake on the PI3K-AKT pathway, so AR pathway inhibition alone leads to compensatory AKT upregulation; targeting AKT can blunt this escape mechanism and potentially improve outcomes when combined with AR pathway inhibitors.
Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
Q: If a patient is frail and not a good CAR-T candidate, what bispecific would you consider and why?
For frail patients, Mosin-Asthumab (or Pola- athumab) is favored due to easier logistics, subcutaneous administration, and a more favorable toxicity profile compared with some alternatives like Glofidimab or Epcoritamab, with the caveat of individual patient tolerance and access.
Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
Q: Okay, so next question, which first-line therapy would you generally recommend for an otherwise healthy stage 4 germinal center B cell type DLBCL with an IPI roughly 3?
The respondent suggests Pola-RCHP as a reasonable frontline option in non-germinal center or higher-risk disease, while acknowledging heterogeneity by cell of origin and the need to consider individual patient factors; in some subgroups (e.g., MCD/cluster subsets), treatment choices may be tailored but the study design limits definitive subdivision recommendations.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Research To Practice

What is Research To Practice about and what kind of topics does it cover?

This program concentrates on cutting-edge oncology practice, featuring expert clinicians and researchers discussing recent data, pivotal trials, and real-world management strategies across solid tumors and hematologic cancers. Episodes frequently cover new therapies, biomarker-guided treatment, sequencing decisions, and practical toxicity management, often tied to major conferences and pivotal symposiums. A standout element is the breadth of high-profile guest experts and the emphasis on translating trial data into clinical decision-making, including transplant eligibility, maintenance strategies, and emerging targeted therapies. Overall, it's a resource for practitioners seeking up-to-date, clinically actionable insights and nuanced expert... more

Where can I find podcast stats for Research To Practice?

Rephonic provides a wide range of podcast stats for Research To Practice. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Research To Practice and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Research To Practice get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Research To Practice, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Research To Practice?

Rephonic provides comprehensive predictive audience data for Research To Practice, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Research To Practice have?

To see how many followers or subscribers Research To Practice has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Research To Practice?

These podcasts share a similar audience with Research To Practice:

1. Two Onc Docs
2. Oncology Today with Dr Neil Love
3. Oncology Brothers: Practice-Changing Cancer Discussions
4. OncLive® On Air
5. Breast Cancer Update

How many episodes of Research To Practice are there?

Research To Practice launched 13 years ago and published 1524 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Research To Practice?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Research To Practice?

Rephonic pulls ratings and reviews for Research To Practice from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Research To Practice?

Rephonic provides full transcripts for episodes of Research To Practice. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Research To Practice?

Recent guests on Research To Practice include:

1. Elizabeth Budde
2. Dr. Stephen Liu
3. Dr. Neeraj Agarwal
4. Ann LaCasce
5. Ursula Matulonis
6. Shannon Westin
7. Alexander Drilon
8. Brad Kahl

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days